Hull and East Yorkshire Hospitals NHS Trust

Hull HU3 2JZ

0 studies enrolling now · 5 studies all time

What they study most

Alcoholic Hepatitis (AH), Hyperlipidemia, Prader-Willi Syndrome, Primary Biliary Cholangitis, Primary Biliary Cirrhosis

Studies at this site

• Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome — Running, not enrolling
• ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed
• Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC) — Completed
• Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH) — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed